NASDAQ:HQY - Healthequity Stock Price, Forecast & News

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

Healthequity Inc (NASDAQ:HQY) announced its quarterly earnings data on Tuesday, December, 3rd. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.33. The business earned $157.12 million during the quarter, compared to analyst estimates of $152.38 million. Healthequity had a return on equity of 11.31% and a net margin of 13.03%. Healthequity's revenue was up 122.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.25 earnings per share. View Healthequity's Earnings History.

Healthequity issued an update on its FY20 earnings guidance on Tuesday, February, 18th. The company provided earnings per share (EPS) guidance of $1.71-1.73 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.51. The company issued revenue guidance of $530-532 million, compared to the consensus revenue estimate of $524.35 million.

12 equities research analysts have issued 1-year target prices for Healthequity's shares. Their forecasts range from $56.00 to $95.00. On average, they anticipate Healthequity's stock price to reach $81.18 in the next twelve months. This suggests that the stock has a possible downside of 2.0%. View Analyst Price Targets for Healthequity.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 1 hold rating, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity.

Media stories about HQY stock have trended very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Healthequity earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Healthequity.

Some companies that are related to Healthequity include Trip.com Group (TCOM), Ctrip.Com International (CTRP), Akamai Technologies (AKAM), Broadridge Financial Solutions (BR), Zillow Group (ZG), LYFT (LYFT), Zillow Group (Z), Fair Isaac (FICO), The Western Union (WU), WEX (WEX), Nielsen (NLSN), Etsy (ETSY), CDK Global (CDK), GrubHub (GRUB) and Ritchie Bros. Auctioneers (RBA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthequity investors own include NVIDIA (NVDA), Input Capital (INP), Circle Oil (COP), Shopify (SHOP), Alibaba Group (BABA), Paypal (PYPL), Twilio (TWLO), Netflix (NFLX), Square (SQ) and Okta (OKTA).

Healthequity's stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (5.55%), Jackson Square Partners LLC (5.04%), Janus Henderson Group PLC (3.37%), State Street Corp (3.09%), Fred Alger Management LLC (2.53%) and Bamco Inc. NY (1.49%). Company insiders that own Healthequity stock include Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan, Larry L Trittschuh and Stephen Neeleman. View Institutional Ownership Trends for Healthequity.

HQY stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Jennison Associates LLC, Geode Capital Management LLC, Royce & Associates LP, AQR Capital Management LLC, Hodges Capital Management Inc., Moody Lynn & Lieberson LLC and Panagora Asset Management Inc.. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Delano Ladd, Frank Corvino and Larry L Trittschuh. View Insider Buying and Selling for Healthequity.

HQY stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Fred Alger Management LLC, Janus Henderson Group PLC, Jackson Square Partners LLC, Raymond James Financial Services Advisors Inc., Raymond James & Associates, Echo Street Capital Management LLC and Bank of Montreal Can. View Insider Buying and Selling for Healthequity.

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of HQY stock can currently be purchased for approximately $82.85.

Healthequity has a market capitalization of $5.87 billion and generates $287.24 million in revenue each year. The company earns $73.90 million in net income (profit) each year or $0.95 on an earnings per share basis. Healthequity employs 1,141 workers across the globe.View Additional Information About Healthequity.

The official website for Healthequity is http://www.healthequity.com/.

Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]